GlassScriptPhysician profile
Marianne Geiger
NPI 1639215015
$3,251.29
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,722 · 2020: $943 · 2021: $483 · 2023: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $545.25 | 2019-2021 | |
| Allergan, INC. | $527.07 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $397.38 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $339.77 | 2019-2021 | |
| Lundbeck LLC | $295.53 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $233.96 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $219.77 | 2019-2020 | |
| Biogen, INC. | $88.17 | 2023 | |
| Owp Pharmaceuticals, INC. | $76.27 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $71.09 | 2019-2020 | |
| Shire North American Group INC | $70.04 | 2019 | |
| Alfasigma USA, INC. | $69.46 | 2020 | |
| Ironshore Pharmaceuticals INC. | $66.32 | 2019-2020 | |
| Alkermes, INC. | $40.24 | 2019 | |
| Jazz Pharmaceuticals INC. | $39.89 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $37.96 | 2019 | |
| Abbvie INC. | $34.91 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $23.78 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.59 | 2020 | |
| Rhodes Pharmaceuticals L.P. | $15.73 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.11 | 2019 | |
| Currax Pharmaceuticals LLC | $12.73 | 2020 | |
| Vertical Pharmaceuticals, LLC | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianne Geiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.